Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial

Abstract Background Fluoropyrimidines (FP) are the third most used chemotherapeutic drugs administered in solid tumors but have cardiotoxic side effects. We aimed to determine whether pre-chemotherapeutic cardiological assessment and management of cardiovascular risk factors could prevent FP-induced...

Полное описание

Библиографические подробности

Главные авторы:	Johanne D. Lyhne, Vibeke B. Hansen, Lone D. Vestergaard, Susanne E. Hosbond, Martin Busk, Mayooran Gnanaganesh, Else Maae, Birgitte M. Havelund, Torben F. Hansen, Signe Timm, Lars H. Jensen, Mads D. Lyhne
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-05-01
Серии:	Cardio-Oncology
Предметы:	Cardio-oncology Cardioprotection Coronary artery calcium score Adverse effects 5-FU Capecitabine
Online-ссылка:	https://doi.org/10.1186/s40959-025-00344-3
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!